[Beta-adrenolytic drugs in the treatment of migraine].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D001812:Blood-Brain Barrier / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D010869:Pindolol / Q000627:therapeutic use; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011433:Propranolol; D010869:Pindolol
Leki beta-adrenolityczny w leczeniu migreny